Selank 5mg

Selank

Selank is a synthetic heptapeptide (seven amino acids) developed by Russian peptide research laboratories as a synthetic analog of the natural tetrapeptide tuftsin, modified with additional amino acid residues to enhance peptide stability and resistance to enzymatic degradation. With the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, Selank represents an engineered modification of native tuftsin (Thr-Lys-Pro-Arg) and has been the subject of substantial cellular neurobiology and biochemical research literature.

Product Specifications

• Compound: Selank
• Class: Synthetic heptapeptide / tuftsin analog
• Parent Peptide: Tuftsin (Thr-Lys-Pro-Arg, naturally occurring tetrapeptide)
• Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
• Molecular Weight: ~751 Da
• Form: Lyophilized powder
• Vial Size: 10mg in 3mL glass vial
• Purity: 99%+ verified by HPLC and mass spectrometry (See COAs)

Research Background

Selank has been investigated in research literature across several scientific contexts:

• Cellular neurobiology research — investigations into peptide effects on cellular signaling pathways in neuronal cell models
• BDNF and neurotrophin pathway research — studies examining cellular responses involving brain-derived neurotrophic factor (BDNF) signaling cascades in cell culture systems
• Tuftsin pharmacology research — comparative cellular research on Selank vs. native tuftsin examining how structural modifications affect peptide stability and biological activity
• Peptide stability engineering — analytical chemistry studies on Selank’s structural modifications and resistance to enzymatic degradation compared to the parent tetrapeptide
• GABAergic and serotonergic pathway research — cellular research literature examining Selank’s interactions with neurotransmitter signaling systems in cell culture models
• Comparative neuropeptide research — analytical studies positioning Selank alongside other short-chain regulatory peptides (including Semax) in cellular research contexts

Selank was originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and has been studied extensively in peer-reviewed research published by the Myasoedov research group and other Russian peptide research laboratories. As a tuftsin-derived peptide, Selank represents an example of natural peptide modification strategies in research peptide chemistry. Foundational research is available through PubMed (pubmed.ncbi.nlm.nih.gov) and the National Institutes of Health’s PMC database (pmc.ncbi.nlm.nih.gov), where researchers can access peer-reviewed studies on Selank cellular biology and tuftsin-derived peptide research.